Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
Plus Therapeutics (NASDAQ:PSTV), a clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for central nervous system (CNS) cancers, will host a business update conference call on Thursday, June 26, 2025, at 9:00 AM ET.
The company will release its business update before market open, followed by a conference call and webcast where management will provide additional details. Participants are encouraged to pre-register through the provided dial-in link, and should join 15 minutes before the start time. A replay will be available on the company's website for 90 days following the live call.
Plus Therapeutics (NASDAQ:PSTV), un'azienda farmaceutica in fase clinica specializzata nello sviluppo di radioterapie mirate per i tumori del sistema nervoso centrale (SNC), terrà una conferenza telefonica di aggiornamento aziendale giovedì 26 giugno 2025 alle 9:00 AM ET.
L'azienda pubblicherà il proprio aggiornamento prima dell'apertura del mercato, seguito da una conferenza telefonica e webcast durante i quali la direzione fornirà ulteriori dettagli. Si consiglia ai partecipanti di preregistrarsi tramite il link per la chiamata fornito e di collegarsi 15 minuti prima dell'inizio. La registrazione della chiamata sarà disponibile sul sito web dell'azienda per 90 giorni dopo la trasmissione in diretta.
Plus Therapeutics (NASDAQ:PSTV), una compañía farmacéutica en etapa clínica enfocada en desarrollar radioterapéuticos dirigidos para cánceres del sistema nervioso central (SNC), llevará a cabo una conferencia telefónica de actualización empresarial el jueves 26 de junio de 2025 a las 9:00 AM ET.
La empresa publicará su actualización comercial antes de la apertura del mercado, seguida de una llamada y webcast donde la dirección proporcionará detalles adicionales. Se recomienda a los participantes pre-registrarse a través del enlace proporcionado y unirse 15 minutos antes del inicio. La repetición estará disponible en el sitio web de la empresa durante 90 días después de la llamada en vivo.
Plus Therapeutics (NASDAQ:PSTV)는 중추신경계(CNS) 암을 위한 표적 방사선 치료제를 개발하는 임상 단계 제약회사로, 2025년 6월 26일 목요일 오전 9시(동부시간)에 사업 업데이트 컨퍼런스 콜을 개최합니다.
회사는 시장 개장 전 사업 업데이트를 발표한 후, 경영진이 추가 세부 정보를 제공하는 컨퍼런스 콜 및 웹캐스트를 진행합니다. 참가자는 제공된 전화 접속 링크를 통해 사전 등록할 것을 권장하며, 시작 15분 전에 접속해야 합니다. 라이브 콜 후 90일간 회사 웹사이트에서 다시보기 서비스를 이용할 수 있습니다.
Plus Therapeutics (NASDAQ:PSTV), une société pharmaceutique en phase clinique spécialisée dans le développement de radiothérapies ciblées pour les cancers du système nerveux central (SNC), organisera une conférence téléphonique de mise à jour commerciale le jeudi 26 juin 2025 à 9h00 ET.
La société publiera sa mise à jour commerciale avant l'ouverture des marchés, suivie d'une conférence téléphonique et d'un webcast où la direction fournira des informations complémentaires. Il est recommandé aux participants de se préinscrire via le lien d'appel fourni et de se connecter 15 minutes avant le début. Une rediffusion sera disponible sur le site web de la société pendant 90 jours après l'appel en direct.
Plus Therapeutics (NASDAQ:PSTV), ein pharmazeutisches Unternehmen in der klinischen Entwicklungsphase, das sich auf die Entwicklung zielgerichteter Radiotherapeutika für zentrale Nervensystem (ZNS)-Krebsarten spezialisiert hat, wird am Donnerstag, den 26. Juni 2025, um 9:00 Uhr ET eine Telefonkonferenz zur Geschäftsaktualisierung abhalten.
Das Unternehmen wird sein Geschäftsupdate vor Börsenöffnung veröffentlichen, gefolgt von einer Telefonkonferenz und einem Webcast, in denen das Management weitere Details bereitstellen wird. Teilnehmer werden gebeten, sich über den bereitgestellten Einwahllink vorab zu registrieren und 15 Minuten vor Beginn beizutreten. Eine Aufzeichnung wird auf der Unternehmenswebsite für 90 Tage nach dem Live-Anruf verfügbar sein.
- None.
- None.
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces that the Company will provide a business update on Thursday, June 26, 2025 before the market open. Plus Therapeutics’ management team will then host a conference call and webcast at 9:00 a.m. ET to discuss and provide additional details.
Webcast and Conference Call
| Date/Time: | Thursday, June 26, 2025 @ 9:00 AM ET | |
| Webcast: | https://edge.media-server.com/mmc/p/97egitn8 | |
| Dial-in Link: | https://register-conf.media-server.com/register/BI66b197347e6041329ab814378ea34059 | |
Participants are encouraged to pre-register any time before the call through the dial-in link. Once registration is completed, participants will be provided a dial-in number with a personalized conference code to access the call. Please dial in 15 minutes prior to the start time.
Following the live call, a replay will be available on the Company’s website under the ‘For Investors’ section. The webcast will be available on the Company’s website for 90 days following the live call.
About Plus Therapeutics
Headquartered in Houston, Texas, Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing, and future potential commercialization of its products. For more information, visit https://www.plustherapeutics.com.
Investor Contact
CORE IR
investor@plustherapeutics.com
FAQ
When is Plus Therapeutics (PSTV) hosting its business update conference call?
How can investors access Plus Therapeutics' (PSTV) conference call?
What is Plus Therapeutics' (PSTV) main business focus?
How long will the PSTV conference call replay be available?
